Last updated on May 2018

Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy


Brief description of study

STUDY AIM To decrease the number of breast cancer patients receiving over treatment of the axilla, in order to positively influence the axillary morbidity rate and quality of life.

PRIMARY OBJECTIVE To determine whether omitting the sentinel lymph node procedure is not inferior to the current axillary staging regimen in clinically node negative breast cancer patients undergoing breast conserving therapy, in terms of regional recurrence rate.

HYPOTHESIS The sentinel lymph node procedure can be safely omitted in clinically node negative breast cancer patients undergoing breast conserving therapy. This will lead to a decreased axillary morbidity rate, with a non-inferior regional recurrence-, distant-disease free- and overall survival rates.

Clinical Study Identifier: NCT02271828

Contact Investigators or Research Sites near you

Start Over

Marjolein L Smidt, MD, PhD

Catharina ziekenhuis
Eindhoven, Netherlands
6.2miles
  Connect »

Marjolein L Smidt, MD, PhD

Maxima Medisch Centrum
Eindhoven, Netherlands
6.2miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.